Skip to content

Ultrasound-based Diagnostic Model for Differentiating Malignant Breast Lesion From Benign Lesion

Ultrasound-based Diagnostic Model for Differentiating Malignant Breast Lesion From Benign Lesion

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03080623
Enrollment
1981
Registered
2017-03-15
Start date
2018-09-08
Completion date
2019-12-31
Last updated
2020-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Female, Diagnoses Disease

Brief summary

This study proposed to construct an ultrasound-based diagnostic model for Differentiating Malignant Breast Lesion From Benign Lesion. This study contains both retrospective and prospective part, which are designed for model construction and independent validation, respectively.This study aims to construct an easy-to-use ultrasound-based model, prove the efficacy of the model for identifying malignant breast lesion from benign lesion, and finally promote the application of this diagnostic model in more clinics.

Interventions

None listed

Sponsors

Peking University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* female * with single breast lesion(maximum diameter\>0.8 cm) * agree to receive follow-up in six months and take the second breast ultrasound six month after the first breast ultrasound, if a benign diagnosis is achieved at the first ultrasound * sign the informed consent

Exclusion criteria

* lost to follow-up * failed to take the second breast ultrasound six month after the first breast ultrasound

Design outcomes

Primary

MeasureTime frameDescription
breast biopsy proved malignant or benign lesionbetween breast ultrasound and biopsy(one week)for patients regarded as malignant by the breast ultrasound, breast biopsy results are used as reference test, which determines the breast lesion is malignant or benign
two breast ultrasound identified benign lesionbetween first detection of breast lesion and the second ultrasound(six month)for patients regarded as benign by the breast ultrasound, they will receive a second breast ultrasound after six month(this is regular examination for patients with first detected breast lesion). If the second ultrasound indicates benign, the lesion will be regarded as benign

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026